✦ LIBER ✦

Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

✍ Scribed by Laura Boehnke Michaud, Dr Aman U. Buzdar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postmenopausal breast cancer, androgens,

✍ Campagnoli, C.; Pasanisi, P.; Castellano, I.; AbbÃ , C.; Brucato, T.; Berrino, F 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 358 KB

Postmenopausal osteoporosis, breast canc

✍ Wiwanitkit, Somsri; Wiwanitkit, Viroj 📂 Article 📅 2013 🏛 Elsevier ⚖ 92 KB

Postmenopausal osteoporosis, breast canc

✍ Wiwanitkit, Somsri; Wiwanitkit, Viroj 📂 Article 📅 2013 🏛 SciELO 🌐 English ⚖ 177 KB

Aromatase Inhibitors in the Treatment of

✍ Dr Emilio Bajetta, Nicoletta Zilembo, Ettore Bichisao 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 191 KB

Postmenopausal women with hormone recept

✍ Ingle, James N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Aromatase Inhibitors as Solely Treatment

✍ Ursula Hille; Philipp Soergel; Florian Länger; Cordula Schippert; Lars Makowski; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB